[1. Miyasaka Y, Barnes ME, Gersh BJ, et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation. 2006;114:119-125.10.1161/CIRCULATIONAHA.105.595140]Search in Google Scholar
[2. Chamberlain AM, Gersh BJ, Alonso A, et al. Decade-long trends in atrial fibrillation incidence and survival: a community study. Am J Med. 2015;128:260-267.10.1016/j.amjmed.2014.10.030]Search in Google Scholar
[3. Chugh SS, Havmoeller R, Narayanan K, et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014;129:837-847.10.1161/CIRCULATIONAHA.113.005119]Search in Google Scholar
[4. Benjamin J. Hirsh, MD, Robert S, et al. Fibrotic Atrial Cardiomyopathy, Atrial Fibrillation, and Thromboembolism. Elsevier. 2015;65:2239-2251.10.1016/j.jacc.2015.03.557]Search in Google Scholar
[5. Disertori M, Franzosi MG, Barlera S, et al. Thromboembolic event rate in paroxysmal and persistent atrial fibrillation: data from the GISSIAF trial. BMC Cardiovasc Disord. 2013;13:28.10.1186/1471-2261-13-28]Search in Google Scholar
[6. Steinberg BA, Hellkamp AS, Lokhnygina Y, et al. Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF trial. Eur Heart J. 2015;36:288-296.10.1093/eurheartj/ehu359]Search in Google Scholar
[7. Healey JS, Connolly SJ, Gold MR, et al. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med. 2012;366:120-129.10.1056/NEJMoa1105575]Search in Google Scholar
[8. Haemers P, Hamdi H, Guedj K, et al. Atrial fibrillation is associated with the fibrotic remodelling of adipose tissue in the subepicardium of human and sheep atria. Eur Heart J. 2017;38:53-61.10.1093/eurheartj/ehv625]Search in Google Scholar
[9. Auer J. Fat: an emerging player in the field of atrial fibrillation. Eur Heart J. 2017;38:62-65.10.1093/eurheartj/ehw013]Search in Google Scholar
[10. Luscher FT. Atrial fibrillation beyond the arrhythmia: hypercoagulability, adipose tissue, and fibrotic remodeling. Eur Heart J. 2017;38:1-3.10.1093/eurheartj/ehw674]Search in Google Scholar
[11. Nattel S, Harada M. Atrial remodeling and atrial fibrillation: recent advances and translational perspectives. J Am Coll Cardiol. 2014;63:2335-2345.10.1016/j.jacc.2014.02.555]Open DOISearch in Google Scholar
[12. Tan AY, Zimetbaum P. Atrial fibrillation and atrial fibrosis. J Cardiovasc Pharmacol. 2011;57:625-629.10.1097/FJC.0b013e3182073c78]Search in Google Scholar
[13. Mikhail S. Dzeshka, Gregory Y.H. Lip, et al. Cardiac Fibrosis in Patients With Atrial Fibrillation. JACC. 2015;66:943-959.10.1016/j.jacc.2015.06.1313]Search in Google Scholar
[14. Filgueiras-Rama D, Price NF, Martins RP, et al. Long-term frequency gradients during persistent atrial fibrillation in sheep are associated with stable sources in the left atrium. Circ Arrhythm Electrophysiol. 2012;5:1160-1167.10.1161/CIRCEP.111.969519]Search in Google Scholar
[15. Gramley F, Lorenzen J, Jedamzik B, et al. Atrial fibrillation is associated with cardiac hypoxia. Cardiovasc Pathol. 2010;19:102-111.10.1016/j.carpath.2008.11.001]Open DOISearch in Google Scholar
[16. Steffel J, Luscher TF, Tanner FC. Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications. Circulation. 2006;113:722-731.10.1161/CIRCULATIONAHA.105.567297]Search in Google Scholar
[17. Daccarett M, Badger TJ, Akoum N, et al. Association of left atrial fibrosis detected by delayed-enhancement magnetic resonance imaging and the risk of stroke in patients with atrial fibrillation. J Am Coll Cardiol. 2011;57:831-838.10.1016/j.jacc.2010.09.049]Open DOISearch in Google Scholar
[18. Spragg DD, Khurram I, Nazarian S. Role of Magnetic Resonance Imaging of Atrial Fibrosis in Atrial Fibrillation Ablation. Arrhythm Electrophysiol Rev. 2013;2:124-127.10.15420/aer.2013.2.2.124]Search in Google Scholar
[19. Chung MK, Martin DO, Sprecher D, et al. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation. 2001;104:2886-2891.10.1161/hc4901.101760]Open DOISearch in Google Scholar
[20. Mihm MJ, Yu F, Carnes CA, et al. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation. 2001;104:174-180.10.1161/01.CIR.104.2.174]Open DOISearch in Google Scholar
[21. Conen D, Ridker PM, Everett BM, et al. A multimarker approach to assess the influence of inflammation on the incidence of atrial fibrillation in women. Eur Heart J. 2010;31:1730-1736.10.1093/eurheartj/ehq146]Open DOISearch in Google Scholar
[22. Jesel L, Arentz T, Herrera-Siklody C, et al. Do atrial differences in endothelial damage, leukocyte and platelet activation, or tissue factor activity contribute to chamber-specific thrombogenic status in patients with atrial fibrillation?. J Cardiovasc Electrophysiol. 2014;25:266-270.10.1111/jce.12312]Search in Google Scholar
[23. Akar JG, Jeske W, Wilber DJ. Acute onset human atrial fibrillation is associated with local cardiac platelet activation and endothelial dysfunction. J Am Coll Cardiol. 2008;51:1790-1793.10.1016/j.jacc.2007.11.083]Open DOISearch in Google Scholar
[24. Pathak RK, Mahajan R, Lau DH, Sanders P. The implications of obesity for cardiac arrhythmia mechanisms and management. Can J Cardiol. 2015;31:203-210.10.1016/j.cjca.2014.10.027]Search in Google Scholar
[25. Abed HS, Samuel CS, Lau DH, et al. Obesity results in progressive atrial structural and electrical remodeling: implications for atrial fibrillation. Heart Rhythm. 2013;10:90-100.10.1016/j.hrthm.2012.08.043]Search in Google Scholar
[26. Steffel J, Luscher TF, Tanner FC. Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications. Circulation. 2006;113:722-731.10.1161/CIRCULATIONAHA.105.567297]Search in Google Scholar
[27. Spronk HM, De Jong AM, Verheule S, et. al. Hypercoagulability causes atrial fibrosis and promotes atrial fibrillation. Eur Heart J. 2017;38:38-50.10.1093/eurheartj/ehw119]Open DOISearch in Google Scholar
[28. Olesen JB, Torp-Pedersen C, Hansen ML, Lip GY. The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study. Thromb Haemost. 2012;107:1172-1179.10.1160/TH12-03-0175]Search in Google Scholar
[29. Hirsh BJ, Copeland-Halperin RS, Halperin JL. Fibrotic atrial cardiomyopathy, atrial fibrillation, and thromboembolism: mechanistic links and clinical inferences. J Am Coll Cardiol. 2015;65:2239-2251.10.1016/j.jacc.2015.03.557]Search in Google Scholar